Osteoblastgenic and Osteogenic Effects of KY-273 with CDK8/19 Inhibitory Activity in Bone Marrow Mesenchymal Stem Cells and Female Rats
Biological and Pharmaceutical Bulletin · 2024
DOI: 10.1248/bpb.b23-00834 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2024. Verfasst von Megumi Yamamoto und 8 weiteren Autor:innen. Beteiligte Einrichtung: United Graduate School of Drug Discovery and Medical Information Science, Gifu University. Hauptthemen laut MEDLINE: Osteoporosis, Mesenchymal Stem Cells. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- United Graduate School of Drug Discovery and Medical Information Science, Gifu University.
- R&D Division, Kyoto Pharmaceutical Industries, Ltd.
- Department of Bioactive Molecules, Pharmacology, Gifu Pharmaceutical University.
Zitieren
APA
Yamamoto, M., Shibata, Y., Ito, Y., Fukui, M., Kioka, H., Shoji, Y., Kitao, T., Shirahase, H., & Hinoi, E. (2024). Osteoblastgenic and Osteogenic Effects of KY-273 with CDK8/19 Inhibitory Activity in Bone Marrow Mesenchymal Stem Cells and Female Rats. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b23-00834
Vancouver
Yamamoto M, Shibata Y, Ito Y, Fukui M, Kioka H, Shoji Y, et al. Osteoblastgenic and Osteogenic Effects of KY-273 with CDK8/19 Inhibitory Activity in Bone Marrow Mesenchymal Stem Cells and Female Rats. Biological and Pharmaceutical Bulletin. 2024. doi:10.1248/bpb.b23-00834
BibTeX
@article{Yamamoto2024,
author = {Yamamoto, Megumi and Shibata, Yui and Ito, Yuma and Fukui, Masaki and Kioka, Hikaru and Shoji, Yoshimichi and Kitao, Tatsuya and Shirahase, Hiroaki and Hinoi, Eiichi},
title = {Osteoblastgenic and Osteogenic Effects of KY-273 with CDK8/19 Inhibitory Activity in Bone Marrow Mesenchymal Stem Cells and Female Rats},
journal = {Biological and Pharmaceutical Bulletin},
year = {2024},
doi = {10.1248/bpb.b23-00834}
}
EUVIMED